
|Slideshows|August 29, 2016
Neuro News Roundup: Treating MS & Epilepsy
Author(s)Mark L. Fuerst
New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.
Advertisement
Early treatment of new onset multiple sclerosis (MS) with interferon β-1b therapy leads to clinical benefits. Several risk factors may help identify epilepsy patients who may be at higher risk for psychosis due to their antiepileptic drug treatment. Topiramate is an appropriate treatment for epilepsy patients with comorbid migraine.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
2
CTAD Poster Shows Etalanetug Reduced Tau Pathology Biomarkers in Dominantly Inherited Alzheimer Disease
3
Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment
4
New Phase 2 Trial to Test TREM2-Stabilizing Agent VHB937 in Alzheimer Disease
5


































